Ikapharmindo Putramas Tbk. vs WIR ASIA Tbk. — how do they compare? Ikapharmindo Putramas Tbk. trades at Rp183 (market cap 304.92B, 13.7K 24h volume), while WIR ASIA Tbk. trades at Rp53 (market cap 620.81B, 28.91M 24h volume). The key difference: WIR ASIA Tbk. is far larger — about 2× Ikapharmindo Putramas Tbk.'s market cap, and WIR ASIA Tbk. is more actively traded (28.91M versus 13.7K). Which is the better fit depends on your goals.
| IKPM | WIRG | |
|---|---|---|
Market Cap | 304.92B | 620.81B |
Volume | 13.7K | 28.91M |
Lot | 137 | 289.05K |
Turnover | 2.49M | 1.51B |
Average Price | 181.39 | 52.37 |
Value | 2.49M | 1.51B |
Indicative Equilibrium Price | — | 53 |
Indicative Equilibrium Volume | — | 11.94K |
Trailing returns across standard periods
Latest headlines on both assets
PT Ikapharmindo Putramas Tbk (the “Company") was established under the name of PT Ikapharm Indonesia based on Notarial Deed of Lien Tanudirdja, S.H., No. 63 dated May 18, 1978. The Company started its commercial operations in 1978. PT Ikapharma Inti Mas is the Parent Company of the Company.
Read more on IKPM →PT WIR ASIA Tbk (the Company) was established on Notarial Deed No. 16 dated August 15, 2011 of Musa Muamarta, S.H. The Company started its commercial operations in 2013.
Read more on WIRG →